Delayed
Hong Kong S.E.
04:08:20 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
0.04
HKD
|
-4.76%
|
|
+21.21%
|
+8.11%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,479
|
431.7
|
326.7
|
203.1
|
127.1
|
149.1
|
Enterprise Value (EV)
1 |
1,303
|
285.7
|
382.7
|
210.6
|
132.3
|
148.5
|
P/E ratio
|
41.3
x
|
85.3
x
|
12.2
x
|
-253
x
|
-143
x
|
-0.64
x
|
Yield
|
1.15%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.51
x
|
5.53
x
|
0.56
x
|
0.27
x
|
0.45
x
|
0.08
x
|
EV / Revenue
|
6.61
x
|
3.66
x
|
0.65
x
|
0.28
x
|
0.47
x
|
0.08
x
|
EV / EBITDA
|
-65.6
x
|
-6.48
x
|
30
x
|
47.2
x
|
-9.23
x
|
-0.92
x
|
EV / FCF
|
-12.5
x
|
-2.86
x
|
-1.73
x
|
-4.01
x
|
-0.98
x
|
1.23
x
|
FCF Yield
|
-7.99%
|
-34.9%
|
-57.8%
|
-24.9%
|
-102%
|
81.1%
|
Price to Book
|
2.22
x
|
0.68
x
|
0.49
x
|
0.3
x
|
0.19
x
|
0.34
x
|
Nbr of stocks (in thousands)
|
1,700,405
|
1,692,760
|
1,692,760
|
1,692,760
|
1,694,450
|
1,694,450
|
Reference price
2 |
0.8700
|
0.2550
|
0.1930
|
0.1200
|
0.0750
|
0.0880
|
Announcement Date
|
18-04-19
|
19-04-25
|
20-04-28
|
21-04-21
|
22-04-29
|
23-04-27
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
197.1
|
78.05
|
587.8
|
760.7
|
283.4
|
1,962
|
EBITDA
1 |
-19.85
|
-44.11
|
12.77
|
4.458
|
-14.33
|
-162.2
|
EBIT
1 |
-23.02
|
-45.97
|
11.32
|
2.334
|
-16.06
|
-163.9
|
Operating Margin
|
-11.68%
|
-58.9%
|
1.93%
|
0.31%
|
-5.67%
|
-8.36%
|
Earnings before Tax (EBT)
1 |
35.92
|
-5.016
|
26.72
|
-0.804
|
-0.888
|
-233.7
|
Net income
1 |
35.86
|
5.071
|
26.72
|
-0.804
|
-0.888
|
-233.7
|
Net margin
|
18.2%
|
6.5%
|
4.54%
|
-0.11%
|
-0.31%
|
-11.91%
|
EPS
2 |
0.0211
|
0.002988
|
0.0158
|
-0.000474
|
-0.000524
|
-0.1379
|
Free Cash Flow
1 |
-104.1
|
-99.78
|
-221.4
|
-52.48
|
-134.5
|
120.4
|
FCF margin
|
-52.83%
|
-127.85%
|
-37.66%
|
-6.9%
|
-47.45%
|
6.14%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0100
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-04-19
|
19-04-25
|
20-04-28
|
21-04-21
|
22-04-29
|
23-04-27
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
56
|
7.45
|
5.19
|
-
|
Net Cash position
1 |
177
|
146
|
-
|
-
|
-
|
0.63
|
Leverage (Debt/EBITDA)
|
-
|
-
|
4.389
x
|
1.672
x
|
-0.362
x
|
-
|
Free Cash Flow
1 |
-104
|
-99.8
|
-221
|
-52.5
|
-134
|
120
|
ROE (net income / shareholders' equity)
|
5.55%
|
0.77%
|
4.12%
|
-0.12%
|
-0.13%
|
-42.2%
|
ROA (Net income/ Total Assets)
|
-2%
|
-3.86%
|
0.96%
|
0.19%
|
-1.36%
|
-16.1%
|
Assets
1 |
-1,789
|
-131.3
|
2,791
|
-419.4
|
65.23
|
1,452
|
Book Value Per Share
2 |
0.3900
|
0.3800
|
0.3900
|
0.4000
|
0.4000
|
0.2600
|
Cash Flow per Share
2 |
0.1100
|
0.0800
|
0.0100
|
0.0100
|
0
|
0
|
Capex
1 |
6.24
|
28.5
|
33.1
|
0.01
|
0.01
|
0
|
Capex / Sales
|
3.16%
|
36.52%
|
5.64%
|
0%
|
0%
|
0%
|
Announcement Date
|
18-04-19
|
19-04-25
|
20-04-28
|
21-04-21
|
22-04-29
|
23-04-27
|
|
1st Jan change
|
Capi.
|
---|
| +8.11% | 8.66M | | -32.21% | 15.27B | | -27.75% | 10.84B | | -26.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -1.17% | 4.71B | | +52.19% | 4.29B | | -14.86% | 3.33B | | -6.93% | 3.01B |
Other Drug Retailers
|